The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The company’s renowned solutions ensure the quality of consumer health products and help stop counterfeiting of pharmaceuticals and medical devices worldwide. OPTEL is also adapting its technologies to create efficiencies in various other sectors that can benefit from end-to-end traceability. Having served the pharmaceutical industry for nearly three decades, ensuring patient safety has always been at the heart of OPTEL’s operations. OPTEL has now taken its commitment to healthcare even closer to people by extending its expertise and technologies to hospital pharmacies. OPTEL provides pharmacies with cutting-edge Track&Trace solutions that perform verification, decommissioning and reverting functionalities in accordance with the compliance requirements of the EU’s Falsified Medicines Directive. OPTEL understands the responsibility that comes with caring for others and partners with key industry stakeholders to support them throughout the care continuum – from the manufacturing facility to the patient, and beyond. Learn more at www.optelgroup.com and www.optelhealthcare.com